India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
BOM:532296 has a market cap or net worth of INR 630.41 billion. The enterprise value is 624.58 billion.
| Market Cap | 630.41B |
| Enterprise Value | 624.58B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
| Current Share Class | 282.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 37.12% |
| Float | 141.59M |
Valuation Ratios
The trailing PE ratio is 35.06 and the forward PE ratio is 26.06.
| PE Ratio | 35.06 |
| Forward PE | 26.06 |
| PS Ratio | 3.55 |
| PB Ratio | 6.00 |
| P/TBV Ratio | 7.87 |
| P/FCF Ratio | 30.20 |
| P/OCF Ratio | 18.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.93, with an EV/FCF ratio of 29.92.
| EV / Earnings | 34.74 |
| EV / Sales | 3.52 |
| EV / EBITDA | 12.93 |
| EV / EBIT | 14.94 |
| EV / FCF | 29.92 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.28 |
| Interest Coverage | 20.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 29.89% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 11.23M |
| Profits Per Employee | 1.14M |
| Employee Count | 15,800 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532296 has paid 7.35 billion in taxes.
| Income Tax | 7.35B |
| Effective Tax Rate | 29.01% |
Stock Price Statistics
The stock price has increased by +3.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.62% |
| 50-Day Moving Average | 2,221.87 |
| 200-Day Moving Average | 2,094.19 |
| Relative Strength Index (RSI) | 50.93 |
| Average Volume (20 Days) | 23,816 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532296 had revenue of INR 177.37 billion and earned 17.98 billion in profits. Earnings per share was 63.69.
| Revenue | 177.37B |
| Gross Profit | 127.59B |
| Operating Income | 41.80B |
| Pretax Income | 25.33B |
| Net Income | 17.98B |
| EBITDA | 48.32B |
| EBIT | 41.80B |
| Earnings Per Share (EPS) | 63.69 |
Balance Sheet
The company has 11.76 billion in cash and 5.94 billion in debt, with a net cash position of 5.83 billion.
| Cash & Cash Equivalents | 11.76B |
| Total Debt | 5.94B |
| Net Cash | 5.83B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 105.12B |
| Book Value Per Share | 372.48 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 34.45 billion and capital expenditures -13.58 billion, giving a free cash flow of 20.87 billion.
| Operating Cash Flow | 34.45B |
| Capital Expenditures | -13.58B |
| Depreciation & Amortization | 6.52B |
| Net Borrowing | -23.57B |
| Free Cash Flow | 20.87B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.94%, with operating and profit margins of 23.57% and 10.14%.
| Gross Margin | 71.94% |
| Operating Margin | 23.57% |
| Pretax Margin | 14.28% |
| Profit Margin | 10.14% |
| EBITDA Margin | 27.24% |
| EBIT Margin | 23.57% |
| FCF Margin | 12.29% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 2.85% |
| FCF Yield | 3.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:532296 is 2,497.27, which is 11.82% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,497.27 |
| Price Target Difference | 11.82% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.21% |
| EPS Growth Forecast (3Y) | 2.01% |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |